EN
News Releases

News Releases

News Releases

Home>News Releases

Headlines

微信图片_20201223103813.jpg

CR Double-Crane acquired 38.7% interest of Dongying Tiandong Pharmaceutical Co., Ltd.’s

CR Double-Crane acquired 38.7% interest of Dongying Tiandong Pharmaceut...


  On December 22, 2020, the signing ceremony between CR Double-Crane and Shandong Haike was held in Dongying, Shandong, and the “Dongying Tiandong Pharmaceutical Equity Transfer...

  On December 22, 2020, the signing ceremony between CR Double-Crane and Shandong Haike was held in Dongying, Shandong, and the “Dong...

Detailed>>

Detailed +

2020.12

2020.12.23

CR Double-Crane acquired 38.7% interest of Dongying Tiandong Pharmaceutical Co., Ltd.’s

CR Double-Crane acquired 38.7% interest of Dongying Tiandong Pharmaceut...


  On December 22, 2020, the signing ceremony between CR Double-Crane and Shandong Haike was held in Dongying, Shandong, and the “Dong...

2020.12

2020.12.14

NIP Pharm received the clinical trial approval of innovative drug NIP046

NIP Pharm received the clinical trial approval of innovative drug NIP046


  On December 9, the innovative drug research and development platform of CR Pharm, NIP Pharm, received the "Notice of Drug Clinical T...

2020.02

2020.02.12

CR Pharma NIP292 tablets received Orphan Drug Designation issued by FDA

CR Pharma NIP292 tablets received Orphan Drug Designation issued by FDA


  On February 5, CR Pharma NIP292 tablets received the Orphan Drug Designation(ODD) issued by Food and Drug Administration(FDA) for th...

2017.08

2017.08.07

Multiple CR Pharma subsidiaries awarded “Top 100 of Chinese Pharmaceutical Industry in 2016”

Multiple CR Pharma subsidiaries awarded “Top 100 of Chinese Pharmaceut...

Recently, the Southern Medicine Economic Institute of China Food and Drug Administration (CFDA) releases “Top 100 of Chinese Pharmaceuti...

2017.06

2017.06.26

CR Pharma is officially included in the FTSE global equity index

CR Pharma is officially included in the FTSE global equity index

China Resources Pharmaceutical Group Limited Group (CR Pharma) (stock code: 3320.HK) is included in the FTSE Global Equity Index Series (...

2017.08

2017.08.25

China Resources Pharmaceutical Delivers Solid Interim Results

China Resources Pharmaceutical Delivers Solid Interim Results

(Hong Kong, 24 August 2017) – China Resources Pharmaceutical Group Limited (CR Pharma) (stock code: 3320), announced its interim results...

2017.06

2017.06.19

CR Pharma Releases Sustainable Development Report 2016

CR Pharma Releases Sustainable Development Report 2016

On June 16th, China Resources Pharmaceutical Group Co., Ltd. (CR Pharma) published its Sustainable Development Report 2016 on the website...
Back to Top